Biorg Med Chem 25:61806189 Bekaii-Saab T, Wesolowski R, Ahn DH, Wu C, Mortazavi A, Lustberg M, Ramaswamy B, Fowler J, Wei L et al (2019) Phase I immunotherapy trial with two chimeric HER-2 B-cell peptide vaccines emulsified in montanide ISA 720VG and nor-MDP adjuvant in patients with advanced solid tumors phase I immunotherapy trial with two B-cell vaccines
This mechanism, if confirmed in human trials, would place GHK-Cu among a very small class of naturally occurring compounds with both anti-inflammatory and anti-androgen properties
its overexpression induces the production and release of inflammatory factors, which are important drivers of carcinogenesis and cancer progression
Brunner, E., Hltenschmidt, W
So he decided to conduct a formal review of the scientific literature in his field
For the synergistic action, drug delivery, and sensing (pH and glucose) dual action approach were integrated that could aid continual monitoring of cutaneous wounds (Fig